Table 2 Buprenorphine treatment episode characteristics for >7-day and >30-day prescription gap thresholds indicating a new treatment episode
|  |  > 7-day gap |  > 30-day gap |
|---|---|---|
Total treatment episodes | 410 | 325 |
Treatment episodes per patient, median (IQR) | 2 (1,3) | 1 (1,2) |
Treatment episodes per patient, maximum | 13 | 6 |
Treatment episode duration, median (IQR) | 62 days (28, 163) | 84Â days, (29, 274) |
Treatment episode gap duration, median (IQR) | 76 days (22,311) | 195Â days (84, 370) |